Idea principal
In 21 NCAA Division I female athletes, three nights of a 40 g pre-sleep casein, α-lactalbumin or carbohydrate drink did not change WHOOP-measured sleep, resting heart rate or HRV compared with placebo (all p > 0.05). The trial tested whether these drinks do harm, over only three nights per condition, so it does not show any benefit.
Study design
Ensayo aleatorizado
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Athletes often sleep poorly or too little, and eating before bed is used to aid recovery, but few controlled trials have compared different pre-sleep macronutrients on objective and subjective sleep in elite female athletes. The authors tested whether casein, α-lactalbumin or carbohydrate before bed would impair sleep or recovery compared with a placebo.
Población y método
Randomized, double-blinded, placebo-controlled crossover trial over 4-8 weeks in 25 NCAA Division I female athletes aged 18-25 years, of whom 21 completed it. Each athlete took four treatments for three consecutive nights each, with at least a three-day washout: 40 g casein (CAS; 160 kcal), 40 g α-lactalbumin (ALA; 160 kcal), 40 g carbohydrate (CHO; 160 kcal) and 40 g placebo (PLA; 5 kcal), about 2 h after the last meal and about 30 min before bed. A WHOOP 4.0 device recorded total sleep time, sleep onset latency, sleep efficiency, resting heart rate and HRV. Morning questionnaires measured sleep quality, sleep onset latency and recovery. A blinded continuous glucose monitor (CGM) was worn by a subset of 6. Repeated-measures ANOVA and Tukey's post hoc testing were used, with p < 0.05.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1No significant treatment effects were seen for total sleep time, sleep onset latency, sleep efficiency, resting heart rate or HRV (p > 0.05).
- 2Across conditions, total sleep time ranged from 7.47-7.62 h, sleep efficiency 91.5-92.0%, resting heart rate 53.5-54.1 bpm and HRV 98.2-103.9 ms.
- 3Subjective sleep quality (69-75%), sleep onset latency (16-20 min) and recovery (61-66%) also showed no significant treatment effects (p > 0.05).
- 4In the 6-person CGM sub-analysis, nocturnal glucose changed with time (p = 0.008) but did not differ among treatments (p = 0.187) and there was no time × treatment interaction (p = 0.550).
Límites e incertidumbre
- 1Only 21 athletes completed it, and the CGM sub-analysis included just 6, so small effects could be missed; the abstract does not report effect sizes or confidence intervals.
- 2Each treatment lasted only three consecutive nights, so longer-term effects of pre-sleep feeding on sleep or body composition are unknown.
- 3Sleep staging and timing came from a consumer wearable (WHOOP 4.0) rather than laboratory polysomnography.
- 4The population was elite collegiate women, so results may not apply to other people. This reading is based on the abstract only.
Relevancia práctica
If you are an athlete who wants a pre-bed protein or carbohydrate snack, this suggests a 40 g serving did not noticeably harm sleep or recovery in this group over short periods. It does not show that it helps sleep. Individual tolerance varies, and people with medical or dietary conditions should check with a clinician or dietitian.
Tus datos
The trial used WHOOP-style data (sleep duration, efficiency, resting heart rate, HRV), the same metrics many wearables record, and its glucose sub-study used a CGM. To test a late snack yourself, change one thing at a time, keep the device and bedtime the same, and compare averages over several nights rather than single nights, since night-to-night values vary.
Cómo interpretar la evidencia
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Sleep is essential for athlete recovery and performance, yet athletes frequently experience restricted or poor-quality sleep. Pre-sleep feeding (PSF) has emerged as a strategy to support recovery, but randomized, double-blinded, crossover trials comparing PSF macronutrient options on objective and subjective sleep outcomes in elite female athletes remain limited.
Methods
Twenty-five National Collegiate Athletic Association (NCAA) Division I female athletes (18-25 years old) were recruited; 21 completed the trial. In a randomized, double-blinded, placebo controlled, crossover design conducted over 4-8 weeks, participants consumed four treatments for three consecutive nights each: 40 g casein protein (CAS; 160 kcal), 40 g α -lactalbumin protein (ALA; 160 kcal), 40 g carbohydrate (CHO; 160 kcal), and 40g of a placebo (PLA; 5 kcal), with a minimum three-day washout between conditions. Supplements were consumed ~2 h after the final meal and ~30 min before bedtime as the last caloric intake of the day. Objective outcomes were obtained from the WHOOP 4.0 device (total sleep time (TST), sleep onset latency (SOL), sleep efficiency (SE), resting heart rate (RHR), and heart rate variability (HRV)). Subjective outcomes were assessed each morning via questionnaires (subjective sleep quality (SSQ), subjective sleep onset latency (SSOL), and subjective recovery (SREC)). Nocturnal interstitial glucose was assessed via blinded continuous glucose monitoring (CGM) in a subset ( n = 6). Sleep and recovery variables were analyzed using one-way repeated-measures analysis of variance (ANOVA) to evaluate treatment effects across the four supplementation conditions. For CGM data, a two-way repeated-measures ANOVA was used to evaluate main effects of treatment and time, as well as the treatment × time interaction. Tukey's post hoc testing was used with significance set at p < 0.05.
Results
No significant treatment effects were observed for TST, SOL, SE, RHR, or HRV ( p > 0.05). TST ranged from 7.47-7.62 h, SE from 91.5-92.0%, RHR from 53.5-54.1 bpm, and HRV from 98.2-103.9 ms across conditions. No significant treatment effects were detected for SSQ, SSOL, or SREC ( p > 0.05); SSQ ranged from 69-75%, SSOL from 16-20 min, and SREC from 61-66%. In the CGM sub-analysis, a main effect of time was observed for nocturnal glucose ( p = 0.008), but no differences among treatments ( p = 0.187) or a time × treatment interaction ( p = 0.550) were detected.
Conclusions
In NCAA Division I female athletes, three consecutive nights of pre-sleep ingestion of CAS, ALA, or CHO did not impair objective or subjective measures of sleep or recovery compared with PLA. These findings demonstrate that pre-sleep feeding, regardless of macronutrient type, can be incorporated without negatively affecting sleep quality or recovery metrics.
Trial registration
ClinicalTrials.gov (Identifier: STUDY00004409).
Fuentes y atribución
Pre-sleep milk-derived proteins do not impair sleep or recovery in elite female athletes.
Paterson KGP, Griest TD, Angeles E, Fenner SP, Eberhardt HK, McKay CR, Helms KLW, Calderon A, Vukovich MD, Ormsbee MJ.
Journal of the International Society of Sports Nutrition · 2026-10-20
DOI: 10.1080/15502783.2026.2746899 ↗PubMed · 42897977 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

